Implant Electrode Circuits for Periprosthetic Infection Sensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Periprosthetic joint infection (PJI) is a significant complication in joint arthroplasty due to the ineffectiveness of antibiotics against biofilm-forming bacteria on implants, leading to invasive treatments with high reinfection rates and mortality, despite advancements in prevention strategies.

Innovation Solution

Medical implants equipped with an electrode array, energy storage device, and power management unit to control electrical stimulation, reducing or eradicating biofilm formation through controlled electrical fields, and incorporating sensors for real-time monitoring and data reporting.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotics are used to treat bacteria on implant surface, then free-floating bacteria can be intercepted effectively, but biofilm bacteria cannot be eradicated due to the protective biofilm layer

Engineering Contradiction:
Improveantibiotic effectivenessVSAvoidbiofilm protection
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the physical parameter of the treatment approach by applying electrical fields (electroporation) to alter the permeability of bacterial cell membranes. This physical parameter change allows antibiotics to penetrate the biofilm layer and reach bacteria that would otherwise be protected, thereby resolving the contradiction between antibiotic effectiveness and biofilm protection.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces an intermediary mechanism (electrical field application through implanted electrodes) that mediates between the antibiotic treatment and the biofilm-protected bacteria. The electrical field acts as a mediator to temporarily disrupt the biofilm barrier, allowing antibiotics to reach their target effectively.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If two-stage revision is performed to treat PJI, then infected implants can be removed and debridement can be performed, but the procedure is highly invasive with high reinfection rates and mortality

Engineering Contradiction:
Improveinfection treatment effectivenessVSAvoidtreatment invasiveness
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by preventing biofilm formation in the first place through electrical field application during the initial implant surgery. The electrodes are implanted simultaneously with the joint replacement, and electrical stimulation is applied prophylactically to prevent bacterial adhesion and biofilm formation, avoiding the need for subsequent invasive two-stage revision procedures.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent enables the implant to serve its own protective function by integrating electrical stimulation capability directly into the implant structure. The implant self-monitors for infection signs and self-treats by applying electrical fields to prevent or eradicate biofilm, eliminating the need for invasive surgical interventions.

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If prevention strategies are implemented including sterilization standards and antibiotic cement, then infection risk can be reduced, but the incidence of PJI has remained constant due to inability to prevent biofilm formation

Engineering Contradiction:
Improveinfection incidenceVSAvoidbiofilm prevention effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent implements preliminary action by applying electrical field stimulation during and after the implant surgery to prevent bacterial adhesion and biofilm formation before infection can establish. This proactive approach complements traditional prevention strategies by adding a physical barrier mechanism that actively prevents biofilm formation rather than relying solely on chemical agents.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent creates a composite functional system combining the mechanical implant structure with electrical stimulation capability. The implant integrates multiple functions: structural support, electrical field generation, and infection monitoring, creating a multi-functional composite system that addresses both mechanical and biological aspects of joint replacement.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Reduces biofilm formation and enhances antibiotic effectiveness, potentially eliminating the need for invasive procedures and lowering reinfection risks, thereby improving patient outcomes.

Implementation Method 1

The power management unit is operative to control electrical stimulation of the electrode array by current supplied by the energy storage device to be at a level which at least reduces formation of a biofilm on at least part of the implant component

Methodology Applied
Scientific EffectElectrical stimulation: Electric Field

Implementation Method 2

The power management unit being operative to control current density through patient tissue between the at least two electrodes of the electrode array

Methodology Applied
Scientific EffectElectrical conduction: Conduction (electrical)

Data Source

PatentUS20260069208A1Medical implants with circuits treating periprosthetic joint infection and other sensing
Publication Date: 2026.03.12 GLOBUS MEDICAL INC
  • US20260069208A1 patent drawing
  • US20260069208A1 patent drawing
  • US20260069208A1 patent drawing

AI summary

A medical implant includes an implant component configured to be implanted in a patient, an electrode array, an energy storage device, and a power management unit. The electrode array includes at least two electrodes spaced apart on the implant component. The energy storage device and power management unit are inside the implant component. The power management unit is operative to control electrical stimulation of the electrode array by current supplied by the energy storage device to be at a level which at least reduces formation of a biofilm on at least part of the implant component while implanted in the patient.